In Delaware, kratom remains legal for adults 21 and older under a newly enacted regulatory framework.
Key Delaware Legislative Updates
- Regulatory Bill Enacted (HS 1 for HB 332): Sponsored by Rep. Melanie Ross Levin, this bill passed both chambers and became law on July 1, 2026. Rather than outright prohibiting natural kratom, it establishes a Kratom Consumer Protection Act framework:
- Age Limit: Restricts sale and distribution to individuals 21 and older.
- Potency & Synthetics Caps: Limits 7-hydroxymitragynine (7-OH) content to no more than 2% of the total alkaloid profile and bans synthetic kratom compounds.
- Labeling & Marketing Rules: Banning marketing targeted at minors (e.g., cartoons, superheroes, or celebrity endorsements) and mandating clear ingredient disclosures.
- Prohibition Measure Failed (SS 1 for SB 262): A competing bill introduced by Sen. Kyra Hoffner aimed to classify kratom under Delaware’s Uniform Controlled Substances Act. However, the General Assembly favored the regulatory approach of HB 332, keeping plain-leaf and standard kratom legal under consumer protection guidelines.
History
SB3160 Creates the Kratom Prohibition Act.
Per Legiscan Status: Introduced on February 2 2026 – 25% progression
Status: Introduced on February 2 2026 – 25% progression
Action: 2026-04-30 – Added as Co-Sponsor Sen. David Koehler
HB5242 Kratom Consumer Protection Act,
Status: Introduced on February 5 2026 – 25% progression
Action: 2026-03-27 – Rule 19(a) / Re-referred to Rules Committee
Pending: House Rules Committee
HB3127 Kratom Consumer Protection Act
Status: Introduced on February 6 2025 – 25% progression
Action: 2026-02-05 – Added Chief Co-Sponsor Rep. Dave Severin
Pending: House Rules Committee
HB4737 Kratom Consumer Protection Act
Status: Introduced on January 30 2026 – 25% progression
Action: 2026-03-27 – Rule 19(a) / Re-referred to Rules Committee
Pending: House Rules Committee
HB4930 Protect Communities from Unregulated Substances Act. Prohibits dispensing, distributing, manufacturing, or selling kratom or tianeptine products for human use unless approved by the U.S. Food and Drug Administration
Status: Introduced on February 4 2026 – 25% progression
Action: 2026-03-27 – Rule 19(a) / Re-referred to Rules Committee
Pending: House Rules Committee
SB1570 Kratom Control Act
Status: Introduced on February 4 2025 – 25% progression
Action: 2026-01-30 – Added as Co-Sponsor Sen. Chris Balkema
Pending: Senate Assignments Committee
HB3129 Amends the Illinois Controlled Substances Act. Adds mitragynine and 7-hydroxymitragynine as Schedule III controlled substances. Repeals the Kratom Control Act.
Status: Introduced on February 6 2025 – 25% progression
Action: 2026-02-05 – Added Chief Co-Sponsor Rep. Dave Severin
Pending: House Rules Committee
